Fig. 7From: Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adultsAssessment of Bone Mineral Density Over Time. Individual lumbar spinal and femur T-scoresBack to article page